Intranasal multivalent vaccines targeting COVID-19 variants of concern

针对关注的 COVID-19 变体的鼻内多价疫苗

• 批准号: 448971
• 负责人: Liu Jun
• 金额: --
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-04-01 至 2022-04-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=448971&lang=en
• 关键词: Animals; Covid-19; Hd-Ad; Sars-Cov-2 Variants; Vaccine

The COVID-19 pandemic, caused by SARS-CoV-2, is being fuelled by emerging variants such as the ones first detected in the United Kingdom (B.1.1.7), South Africa (B.1.351) and Brazil (P.1) and now more recently in California (B.1.427/B.1.429). These varian

由SARS-COV-2引起的COVID-19大流行正在由新兴变体（例如英国（B.1.1.7），南非（B.1.351）和巴西（P.1）以及现在在加利福尼亚州（B.1.427/B.1.429）中首次检测到的新兴变体。这些粒子